BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahman MM, Tollefsbol TO. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects. Methods 2021;187:77-91. [PMID: 32315755 DOI: 10.1016/j.ymeth.2020.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Breier D, Peer D. Genome editing in cancer: Challenges and potential opportunities. Bioactive Materials 2023;21:394-402. [DOI: 10.1016/j.bioactmat.2022.08.013] [Reference Citation Analysis]
2 Rad FT, Gargari BN, Ghorbian S, Farsani ZS, Sharifi R. Inhibiting the growth of melanoma cells via hTERT gene editing using CRISPR-dCas9-dnmt3a system. Gene 2022;828:146477. [PMID: 35398175 DOI: 10.1016/j.gene.2022.146477] [Reference Citation Analysis]
3 Tang SC, Vijayakumar U, Zhang Y, Fullwood MJ. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer. Cancers (Basel) 2022;14:2866. [PMID: 35740532 DOI: 10.3390/cancers14122866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Klupczyńska EA, Ratajczak E. Can Forest Trees Cope with Climate Change?-Effects of DNA Methylation on Gene Expression and Adaptation to Environmental Change. Int J Mol Sci 2021;22:13524. [PMID: 34948318 DOI: 10.3390/ijms222413524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Balla B, Tripon F, Banescu C. From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques. Int J Mol Sci 2021;22:10065. [PMID: 34576226 DOI: 10.3390/ijms221810065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhi L, Su X, Yin M, Zhang Z, Lu H, Niu Z, Guo C, Zhu W, Zhang X. Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges. Cell Immunol 2021;369:104436. [PMID: 34500148 DOI: 10.1016/j.cellimm.2021.104436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pacheco MB, Camilo V, Henrique R, Jerónimo C. Epigenetic Editing in Prostate Cancer: Challenges and Opportunities. Epigenetics 2021;:1-25. [PMID: 34130596 DOI: 10.1080/15592294.2021.1939477] [Reference Citation Analysis]
8 Li Y. Advance epigenetics methods in biomedicine. Methods 2021;187:1-2. [PMID: 33545312 DOI: 10.1016/j.ymeth.2021.01.010] [Reference Citation Analysis]
9 Martinez-Escobar A, Luna-Callejas B, Ramón-Gallegos E. CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research. Front Oncol 2020;10:604948. [PMID: 33614489 DOI: 10.3389/fonc.2020.604948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]